Next Science Ltd (OTCPK:NXSCF)
$ 0.1035 0.0035 (3.5%) Market Cap: 30.78 Mil Enterprise Value: 26.95 Mil PE Ratio: 0 PB Ratio: 3.45 GF Score: 46/100

Full Year 2021 Next Science Ltd Earnings Call Transcript

Feb 27, 2022 / 11:00PM GMT
Operator

Good day, and thank you for standing by. And welcome to the Next Science Limited 2021 Full Year Results Conference Call. (Operator Instructions) After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions)

I'd now like to hand the conference over to your first speaker today, Managing Director, Judith Mitchell. Thank you. Please go ahead.

Judith Mitchell
Next Science Limited - MD, CEO & Executive Director

Thank you very much, and good morning, everybody, and thank you for joining us on the call this morning. My name is Judy Mitchell, and I'm the Managing Director for Next Science. So, let's start by moving to Slide 3 on the deck that was put up on the ASX on the 23rd of this month -- of, yes, this month, February. So we are actually very happy to report that 2021 was a record year of sales for the company with 160% growth year-on-year. We saw record growth in Bactisure sales as the surgery market started to recover in the U.S. We saw expansion of our BlastX customer base as we pulled the product back from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot